Zynex Inc (ZYXI) USD0.001

Sell:$2.40Buy:$2.41$0.13 (4.96%)

NASDAQ:1.26%
Market closed | Prices delayed by at least 15 minutes
Sell:$2.40
Buy:$2.41
Change:$0.13 (4.96%)
Market closed | Prices delayed by at least 15 minutes
Sell:$2.40
Buy:$2.41
Change:$0.13 (4.96%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Key people

Thomas Sandgaard
Chairman of the Board, President, Chief Executive Officer
Daniel J. Moorhead
Chief Financial Officer
Anna Lucsok
Chief Operating Officer
Michael D. Cress
Independent Director
Joshua R. Disbrow
Independent Director
Barry D. Michaels
Independent Director
Click to see more

Key facts

  • EPIC
    ZYXI
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US98986M1036
  • Market cap
    $73.75m
  • Employees
    1,000
  • Shares in issue
    40.08m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.